Longitudinal Tracking of ALK-positive Lung Cancer From Plasma Using Circulating-Tumor RNA and Circulating-Tumor DNA in the BRIGHTSTAR Clinical Trial

Autor: Heeke, S., Gandhi, S., Tran, H., Lam, V., Pek, M., Poh, J., Ngeow, K. Chin, Heymach, J., Elamin, Y.
Zdroj: In The Journal of Liquid Biopsy November 2023 1 Supplement
Databáze: ScienceDirect